← FDA Drug Approvals (Drugs@FDA)

REZLIDHIA

NDA · New Drug Application · Sponsor: RIGEL PHARMS · Approved 2022-12-01

Drug application

FDA Application #

NDA215814

Application type

New Drug Application

Brand name

REZLIDHIA

Generic name

OLUTASIDENIB

Active ingredients

OLUTASIDENIB

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

RIGEL PHARMS

Manufacturer

Rigel Pharmaceuticals, Inc.

First approval

2022-12-01

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown